Innovation doesn’t take place in a vacuum. Through collaboration with physicians and scientists both across the U.S. and internationally, PureForm BioSciences is working to develop the entire field of cannabinoid-based medicine.
Supporting our approach is rigorous clinical research, conducted by world-renowned academic institutions. The company has partnered with the University of California, Los Angeles (UCLA) to launch an extensive cannabinoid research program, advancing the science behind medical applications of cannabinoids in a number of therapeutic areas. In addition to UCLA, we are engaging Duke University, Massachusetts General Hospital (Harvard Medical School) and University of Pennsylvania to build a multidisciplinary research collaborative.